MH
PFE icon

Mark Hillman’s Pfizer PFE Stock Holding History

Mark Hillman’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.2M Sell
174,610
-13,327
-7% -$349K 3.04% 13
2026
Q1 		$5.28M Buy
187,937
+12,633
+7% +$336K 3.66% 6
2025
Q4 		$4.37M Sell
175,304
-41,248
-19% -$1.04M 2.75% 13
2025
Q3 		$5.52M Sell
216,552
-18,076
-8% -$446K 3.21% 9
2025
Q2 		$5.69M Sell
234,628
-6,953
-3% -$162K 3.1% 11
2025
Q1 		$6.12M Sell
241,581
-78,388
-24% -$2.05M 3.01% 16
2024
Q4 		$8.49M Buy
319,969
+88,910
+38% +$2.41M 3.15% 10
2024
Q3 		$6.69M Sell
231,059
-91
-0% -$2.65K 2.29% 23
2024
Q2 		$6.47M Sell
231,150
-992
-0.4% -$27.3K 2.28% 26
2024
Q1 		$6.44M Buy
232,142
+44,347
+24% +$1.23M 2.07% 30
2023
Q4 		$5.41M Buy
+187,795
New +$5.68M 1.87% 35
2021
Q4 		– Sell
-176,532
Closed -$7.59M – 58
2021
Q3 		$7.59M Buy
176,532
+7,427
+4% +$329K 2.67% 22
2021
Q2 		$6.62M Buy
169,105
+450
+0.3% +$17.5K 2.52% 24
2021
Q1 		$6.11M Buy
168,655
+60,187
+55% +$2.14M 2.68% 23
2020
Q4 		$3.99M Buy
108,468
+13,992
+15% +$513K 2.16% 29
2020
Q3 		$3.29M Sell
94,476
-116
-0.1% -$4.07K 2.32% 27
2020
Q2 		$2.94M Buy
94,592
+7
+0% +$238 2.14% 30
2020
Q1 		$2.93M Buy
94,585
+6,358
+7% +$217K 2.81% 18
2019
Q4 		$3.28M Buy
+88,227
New +$3.14M 2.32% 21
2013
Q4 		$735K Hold
25,277
– – 1.1% 34
2013
Q3 		$749K Hold
25,277
– – 1.15% 34
2013
Q2 		$701K Buy
+25,277
New +$698K 0.98% 42

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mark Hillman's PFE Position: Q2 2026 in Review

Mark Hillman reduced its Pfizer (PFE) stake by 7.1% in Q2 2026, selling an estimated $349K and leaving 174,610 shares worth $4.2M. The position accounts for 3.04% of the portfolio, ranked #13.

Mark Hillman first reported a position in PFE in Q2 2013 and has held it in 22 quarters since. The position peaked at $8.49M in Q4 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Mark Hillman held 174,610 shares of Pfizer worth $4.2M as of Q2 2026.
  • Mark Hillman sold 13,327 Pfizer shares in Q2 2026, an estimated $349K.
  • Pfizer made up 3.04% of Mark Hillman's portfolio in Q2 2026, its #13 holding.
  • Mark Hillman first reported a position in Pfizer in Q2 2013 and has held it in 22 quarters since.
  • Mark Hillman's Pfizer position peaked at $8.49M in Q4 2024.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hillman Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.